GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 87 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $359,000 | +552.7% | 24,578 | +82.7% | 0.06% | +321.4% |
Q1 2020 | $55,000 | -38.2% | 13,452 | -8.1% | 0.01% | +16.7% |
Q3 2019 | $89,000 | -2.2% | 14,632 | +3.1% | 0.01% | +140.0% |
Q2 2018 | $91,000 | -79.9% | 14,196 | -59.8% | 0.01% | -79.2% |
Q1 2017 | $452,000 | – | 35,290 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versor Investments LP | 2,664,831 | $63,689,000 | 3.80% |
Chicago Capital Management, LLC | 318,113 | $7,603,000 | 3.54% |
First Trust Capital Management L.P. | 564,758 | $13,498,000 | 2.64% |
WATER ISLAND CAPITAL LLC | 1,693,162 | $40,467,000 | 2.47% |
Sand Grove Capital Management LLP | 992,068 | $23,710,000 | 2.31% |
EMC Capital Management | 121,023 | $2,892,000 | 2.06% |
OMNI PARTNERS LLP | 1,540,671 | $36,822,000 | 1.82% |
TIG Advisors, LLC | 1,774,849 | $42,419,000 | 1.60% |
Cowen Prime Services LLC | 174,850 | $4,179,000 | 1.58% |
G2 Investment Partners Management LLC | 396,400 | $9,474,000 | 1.50% |